Evidence map›Paper›PMID 21725997›Full record

ArticleHepatology (Baltimore, Md.)2011

Inflammatory response to liver fluke Opisthorchis viverrini in mice depends on host master coregulator MTA1, a marker for parasite-induced cholangiocarcinoma in humans.

Sujit S Nair, Anitha Bommana, Suresh B Pakala, Kazufumi Ohshiro, Amanda J Lyon, Sutas Suttiprapa, Maria V Periago, Thewarach Laha, Peter J Hotez, Jeffrey M Bethony and 3 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Hepatology (Baltimore, Md.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Inflammatory responses toOpen veterinary journal · 2024
    Article
  2. Article
  3. Review
  4. Article
  5. Interleukin (IL)-21 in Inflammation and Immunity During Parasitic Diseases.Frontiers in cellular and infection microbiology · 2019
    Review
  6. Article
  7. The role of evolutionary biology in research and control of liver flukes in Southeast Asia.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2016
    Review
  8. Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Sujit S NairDepartment of Biochemistry and Molecular Biology, George Washington University, Washington, DC 20016, USA.
Anitha Bommana
Suresh B Pakala
Kazufumi Ohshiro
Amanda J Lyon
Sutas Suttiprapa
Maria V Periago
Thewarach Laha
Peter J Hotez
Jeffrey M Bethony
Banchob Sripa
Paul J Brindley
Rakesh Kumar
George Washington University · USKhon Kaen University · TH

Funding

Pathogenesis of Liver Fluke Induced Cancer in ThailandU01AI065871 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI BRINDLEY, PAUL J · 2005 to 2009
$3.5M
Role of Metastatic Tumor Antigen-1 in Mammary GlandR01CA098823 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KUMAR, RAKESH · 2003 to 2013
$3.1M
Biomarkers of Opisthorchis viverrini-induced cholangiocarcinomaR01CA155297 · NCI · GEORGE WASHINGTON UNIVERSITY · PI BETHONY, JEFFREY MICHAEL, BRINDLEY, PAUL J · 2011 to 2015
$2.7M
NCI NIH HHS CA155297NCI NIH HHS CA98823NCI NIH HHS CA98823-S1NCI NIH HHS R01 CA098823NCI NIH HHS R01 CA155297NIAID NIH HHS AI065871NIAID NIH HHS U01 AI065871
6 · The paper itself

Abstract

unlabelledBased on the recently established role for the master coregulator MTA1 and MTA1-containing nuclear remodeling complexes in oncogenesis and inflammation, we explored the links between parasitism by the carcinogenic liver fluke Opisthorchis viverrini and this coregulator using both an Mta1(-/-) mouse model of infection and a tissue microarray of liver fluke-induced human cholangiocarcinomas (CCAs). Intense foci of inflammation and periductal fibrosis in the liver and kidneys of wild-type Mta1(+/+) mice were evident at 23 days postinfection with O. viverrini. In contrast, little inflammatory response was observed in the same organs of infected Mta1(-/-) mice. Livers of infected Mta1(+/+) mice revealed strong up-regulation of fibrosis-associated markers such as cytokeratins 18 and 19 and annexin 2, as determined both by immunostaining and by reverse-transcription polymerase chain reaction compared with infected Mta1(-/-) mice. CD4 expression was up-regulated by infection in the livers of both experimental groups; however, its levels were several-fold higher in the Mta1(+/+) mice than in infected Mta1(-/-) mice. Mta1(-/-) infected mice also exhibited significantly higher systemic and hepatic levels of host cytokines such as interleukin (IL)-12p70, IL-10, and interferon-γ compared with the levels of these cytokines in the Mta1(+/+) mice, suggesting an essential role of MTA1 in the cross-regulation of the Th1 and Th2 responses, presumably due to chromatin remodeling of the target chromatin genes. Immunohistochemical analysis of ≈ 300 liver tissue cores from confirmed cases of O. viverrini-induced CCA showed that MTA1 expression was elevated in >80% of the specimens.

conclusionThese findings suggest that MTA1 status plays an important role in conferring an optimal cytokine response in mice following infection with O. viverrini and is a major player in parasite-induced CCA in humans.

Indexed as

AnimalsAntigens, HelminthBile Duct NeoplasmsBile Ducts, IntrahepaticBiomarkersCholangiocarcinomaCytokinesDisease Models, AnimalEnzyme-Linked Immunosorbent AssayFasciola hepaticaHistone DeacetylasesHost-Parasite InteractionsHumansImmunohistochemistryLiver Neoplasms, ExperimentalMiceAntigens, HelminthBiomarkersCytokinesHistone DeacetylasesMTA1 protein, humanRepressor ProteinsTrans-Activators

Identifiers

PMID21725997
PMCPMC3184196
OpenAlexW2040005858

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.